Changes to Brazilian legislation regarding the use of RSHO™ cannabis products has created waves in the medical marijuana community around the world. RSHO™ produces a high-quality medical grade cannabis oil that is abundant in the cannabinoid CBD (cannabidiol). This natural botanical product is being imported into Brazil for four indications: epilepsy, Parkinson’s disease, chronic pain conditions and now cancer. These products are created from hemp oil and lack the THC content that leads to the “high” that is incorrectly attributed to medical marijuana products.
According to the National Institutes of Health and the National Cancer Institute, an estimated 1,658,370 cases of cancer were diagnosed in 2015 alone. Another 589,430 of those who were diagnosed would have died from cancer. In the same year, the most common cancers were breast, lung, prostate, bronchus, colon, rectum and bladder cancer as well as non-Hodgkin lymphoma, thyroid, kidney, renal pelvis, endometrial, leukemia and pancreatic cancer. Out of every 100,000 people, 454.8 will receive a new cancer diagnosis.
The number of men who die from cancer is significantly higher than the number of women, and the risk of cancer mortality is highest among African American men and lowest among Asian and Pacific Islander women. Nearly 40 percent of all men and women will receive a cancer diagnosis at some point in their lives. A shocking 15,780 of those individuals are diagnosed between the ages of 0 and 19 and another 1,960 of those children and adolescents diagnosed with cancer will die. Cancer is the leading cause of death around the world, and South America is among the most common world regions for cancer diagnosis.
Brazilian Laws Regarding Medical Marijuana
Brazil has shown support for the medicinal use of the hemp-based oils produced by Medical Marijuana, Inc. by not only allowing the legal importation of RSHO™ cannabis oil but providing it through government-subsidized health insurance. Including cancer, RSHO™ hemp CBD oil has been also approved for import to Brazil for epilepsy, Parkinson’s disease and chronic pain. Listed among the properties of CBD are: a reduction in nausea, cancer prevention, pain relief, spasm relief and reduced frequency of seizures.
Marijuana and its extracts are currently legal in 24 U.S. states as well as Guam and Puerto Rico, hemp CBD oil is non-psychoactive and fully legal for access in all 50 states without any medical recommendation. Stuart W. Titus, PhD, the Chief Executive Officer of Medical Marijuana, Inc., announced a focus on providing accessible CBD oil to consumers across the world. The legalization of the products in Brazil is a promising start to improved access worldwide.
RSHO Success Stories with International Impact
The Brazilian government’s decision to legalize hemp oil products for four major indications came as the result of a struggle by Brazilian mother Katiele Fischer to use RSHO™ products to help her ailing daughter. Fischer discovered RSHO™ oil on the blog of another mother in America whose young daughter had found relief from her near-constant seizures for the first time after trying cannabis oil.